Navigation Links
Cheap, rapid hand-held check for HIV

Political pressure has finally seen the price of antiretroviral therapy for HIV slashed in poorer countries. But a lack of cheap, simple diagnostics to enable doctors to use these complex treatments remains a stumbling block.

Now scientists from two New York universities believe they have the solution: a hand-held sensor that checks the health of a patient's immune system in seconds. At the moment it can take a week to get the same results back from the lab, "and that's if they don't get lost", says Glenda Gray, a consultant physician and head of perinatal HIV research at the University of the Witwatersrand in Johannesburg, South Africa.

The sensor measures the quantity of key immune cells called CD4+ cells in the blood. A gradual depletion of CD4+ cells, which orchestrate the immune response to tumours and infections, is a sure sign that HIV is damaging a person's health: some clinical definitions of AIDS say that once a person's CD4+ count falls below 200 cells per microlitre of blood, he or she has developed the condition.

Doctors rely on CD4+ measurements to decide when to start drug treatments and to gauge whether a patient is responding to them.

To make the device, researchers from Cornell University in Ithaca and the University at Albany coated electrodes with antibodies specific to CD4+ cells. When a small sample of blood is put onto a chip bearing these electrodes, the antibodies grab hold of the CD4+ cells. The captured cells then impede the flow of current across the electrodes, allowing the density of CD4+ cells to be calculated.

To check that only CD4+ cells were sticking to the electrodes the team added a label to blood samples consisting of a fluorescent dye tagged to a further set of antibodies specific for CD4+ cells. They then used an electron microscope to check which cells had been captured. By counting the captured cells, the researchers devised a scale linking electrical resistance with the density of cells in the blood (Biosensors & Bioelectronics, vol 21, p 696).

"It is the first step towards a hand-held, simple, inexpensive device that will measure the number of CD4+ cells in human blood without the need for extensive infrastructure," says James Turner, a biophysicist at the University at Albany, who led the research.


'"/>

Source:New Scientist Boston office


Related biology news :

1. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
2. Researchers develop rapid diagnostic tool for pathogen identification
3. Variation in HIVs ability to disable host defenses contributes to rapid evolution
4. New technique rapidly detects illness-causing bacteria
5. NASA satellite data provides rapid analysis of Amazon deforestation
6. Prions rapidly remodel good protein into bad, Brown study shows
7. Customized gene chip provides rapid detection of genetic changes in childrens cancer
8. A bugs life: Exceptional genomic stability yet rapid protein evolution in a carpenter ant mutualist
9. Scientists must offer solutions for conserving tropical forests in a rapidly changing world
10. Radiation-armed robot rapidly destroys human lung tumors
11. New strategy rapidly identifies cancer targets
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
(Date:3/24/2017)... , March 24, 2017 The Controller General ... Controller Mr. Abdulla Algeen have received the prestigious international IAIR ... Continue Reading ... ... picture) and Deputy Controller Abdulla Algeen (small picture on the right) have ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... DIEGO , March 27, 2017  Trovagene, Inc. ... that its Chief Executive Officer, Bill Welch , ... April 4, 2017 at 9:00 AM EDT at the ... .  Bill Welch, and Chief Scientific Officer, Mark ... with investors during the conference.   The presentation ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Human ... report to their offering. ... This report analyzes the Global market for Human Embryonic ... are provided for the period 2014 through 2022. Market data and ... The report profiles 25 companies including many key and niche players ...
(Date:3/23/2017)... ... 2017 , ... AxioMed president, Jake Lubinski, describes the AxioMed ... deformed, which is identical to how the human discs work to distribute force. ... to its natural state along a hysteresis curve, exactly like a healthy human ...
(Date:3/23/2017)... 2017  GlobeImmune, Inc. today announced it has entered ... 12,835,490 shares of its common stock to NantCell, Inc., ... with the sale of its common stock, NantCell has ... to GlobeImmune 200,000 shares, an estimated $2.0 million in ... are pleased to enter into this strategic agreement with ...
Breaking Biology Technology: